← FDA DRUG APPROVALS

FDA ANDA · ANDA078656

VALACYCLOVIR HYDROCHLORIDE

Sponsor: HIKMA

APPLICATION
ANDA078656
TYPE
ANDA
ORIGINAL APPROVAL
2010-05-24
LATEST ACTION
2024-11-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

VALACYCLOVIR HYDROCHLORIDEDiscontinued
VALACYCLOVIR HYDROCHLORIDE EQ 1GM BASE · TABLET · ORAL
VALACYCLOVIR HYDROCHLORIDEDiscontinued
VALACYCLOVIR HYDROCHLORIDE EQ 500MG BASE · TABLET · ORAL

Approval history

2024-11-19Labeling · Supplement 4 · standardAP
2020-09-10Labeling · Supplement 3 · standardAP
2010-05-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →